SAHPRA lifts pause on J&J vaccine with conditions Search Polity Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range. To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options. With... Clear Search Sponsored by Sponsored by The South African Health Products Regulatory Authority (SAHPRA) has recommended that the pause of the Sisonke vaccine trial study using the Johnson & Johnson Covid-19 vaccine be lifted, provided that specific conditions are met. The US, South Africa and the European Union temporarily stopped the rollout of the Johnson & Johnson jab, after six cases of rare blood clotting were reported in the US.